{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:46:59Z","timestamp":1782283619593,"version":"3.54.5"},"reference-count":55,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"am","delay-in-days":331,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014480","name":"Horizon Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014480","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.semarthrit.2021.06.009","type":"journal-article","created":{"date-parts":[[2021,6,20]],"date-time":"2021-06-20T09:33:42Z","timestamp":1624181622000},"page":"895-902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Identification and characterization of peripheral vascular color-coded DECT lesions in gout and non-gout patients: The VASCURATE study"],"prefix":"10.1016","volume":"51","author":[{"given":"Tristan","family":"Pascart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Carpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyon K","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laur\u00e8ne","family":"Norberciak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Ducoulombier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Luraschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Houvenagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Verclytte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Becce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Budzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2021.06.009_bib0001","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","volume":"388","author":"Dalbeth","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0002","first-page":"27","article-title":"Gout: state of the art after a decade of developments","volume":"58","author":"Pascart","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0003","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.107.703389","article-title":"Independent impact of gout on mortality and risk for coronary heart disease","volume":"116","author":"Choi","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0004","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1136\/annrheumdis-2016-210357","article-title":"Cardiovascular risk of patients with gout seen at rheumatology clinics following a structured assessment","volume":"76","author":"Andres","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9051295","article-title":"Association of Specific Comorbidities with Monosodium Urate Crystal Deposition in Urate-Lowering Therapy-Naive Gout Patients: A Cross-Sectional Dual-Energy Computed Tomography Study","volume":"9","author":"Pascart","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0006","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12916-017-0890-9","article-title":"Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options","volume":"15","author":"Bardin","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0007","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaa920","article-title":"Crystal deposition measured with Dual-Energy Computed Tomography: association with mortality and cardiovascular risks in gout","author":"Marty-Ane","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0008","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nrrheum.2014.124","article-title":"Improving cardiovascular and renal outcomes in gout: what should we target?","volume":"10","author":"Richette","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0009","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/annrheumdis-2012-202421","article-title":"Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout","volume":"73","author":"Perez-Ruiz","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0010","article-title":"Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout","author":"Hansildaar","year":"2020","journal-title":"Lancet Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.06.009_bib0011","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1185\/03007995.2015.1087980","article-title":"Inflammation: a possible mechanism for a causative role of hyperuricemia\/gout in cardiovascular disease","volume":"31","author":"Perez-Ruiz","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0012","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0013","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/jamacardio.2019.3201","article-title":"Dual-Energy Computed Tomography Detection of Cardiovascular Monosodium Urate Deposits in Patients With Gout","volume":"4","author":"Klauser","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005308","article-title":"Prevalence of birefringent crystals in cardiac and prostatic tissues, an observational study","volume":"4","author":"Park","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0015","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/jcp.38.8.873","article-title":"Aortic valvular tophus: identification by X-ray diffraction of urate and calcium phosphates","volume":"38","author":"Gawoski","year":"1985","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0016","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9149(01)01621-6","article-title":"Identification of uric acid and xanthine oxidase in atherosclerotic plaque","volume":"88","author":"Patetsios","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0017","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/art.39581","article-title":"Silent Monosodium Urate Crystal Deposits Are Associated With Severe Coronary Calcification in Asymptomatic Hyperuricemia: An Exploratory Study","volume":"68","author":"Andres","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0018","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1055\/s-0035-1569253","article-title":"Dual-Energy CT: Basic Principles, Technical Approaches, and Applications in Musculoskeletal Imaging (Part 1)","volume":"19","author":"Omoumi","year":"2015","journal-title":"Semin Musculoskelet Radiol"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0019","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/annrheumdis-2019-215315","article-title":"2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout","volume":"79","author":"Richette","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0020","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1136\/ard.2008.099713","article-title":"Dual energy computed tomography in tophaceous gout","volume":"68","author":"Choi","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0021","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.joca.2019.05.007","article-title":"Dual-energy computed tomography in calcium pyrophosphate deposition: initial clinical experience","volume":"27","author":"Pascart","year":"2019","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0022","article-title":"Is dual-energy computed tomography able to identify early calcium crystal deposition in the knees of calcium pyrophosphate deposition patients?","author":"Budzik","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0023","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11926-020-0890-1","article-title":"Utility of Ultrasound and Dual Energy CT in Crystal Disease Diagnosis and Management","volume":"22","author":"Filippou","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0024","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X20936060","article-title":"Dual-energy computed-tomography-based discrimination between basic calcium phosphate and calcium pyrophosphate crystal deposition in vivo","volume":"12","author":"Pascart","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13075-017-1381-2","article-title":"Ultrasonography and dual-energy computed tomography provide different quantification of urate burden in gout: results from a cross-sectional study","volume":"19","author":"Pascart","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0026","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/art.40929","article-title":"Effects of Allopurinol Dose Escalation on Bone Erosion and Urate Volume in Gout: A Dual-Energy Computed Tomography Imaging Study Within a Randomized, Controlled Trial","volume":"71","author":"Dalbeth","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0027","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/art.41063","article-title":"Effects of Conventional Uric Acid-Lowering Therapy on Monosodium Urate Crystal Deposits","volume":"72","author":"Ellmann","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2021.105178","article-title":"Drastic monosodium urate crystal dissolution with febuxostat and benzbromarone monitored and quantified by dual-energy computed tomography","author":"Pascart","year":"2021","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0029","doi-asserted-by":"crossref","first-page":"W103","DOI":"10.2214\/AJR.13.11396","article-title":"Artifacts in dual-energy CT gout protocol: a review of 50 suspected cases with an artifact identification guide","volume":"203","author":"Mallinson","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2214\/AJR.14.13901","article-title":"Getting the Most From Your Dual-Energy Scanner: Recognizing, Reducing, and Eliminating Artifacts","volume":"206","author":"Coupal","year":"2016","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0031","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/jamacardio.2019.5804","article-title":"Identification of Cardiovascular Monosodium Urate Crystal Deposition in Patients With Gout Using Dual-Energy Computed Tomography","volume":"5","author":"Becce","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0032","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/annrheumdis-2016-209467","article-title":"Treat-to-target (T2T) recommendations for gout","volume":"76","author":"Kiltz","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0033","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jbspin.2020.05.002","article-title":"2020 recommendations from the French Society of Rheumatology for the management of gout: Urate-lowering therapy","volume":"87","author":"Pascart","year":"2020","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0034","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","article-title":"2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"74","author":"Neogi","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0036","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.RVI.0000191361.02857.DE","article-title":"CT angiography of peripheral arterial disease","volume":"17","author":"Fleischmann","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0037","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jvs.2003.12.005","article-title":"The popliteal artery, an unusual muscular artery with wall properties similar to the aorta: implications for susceptibility to aneurysm formation?","volume":"39","author":"Debasso","year":"2004","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0038","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2214\/AJR.19.22222","article-title":"Not All Green Is Tophi: The Importance of Optimizing Minimum Attenuation and Using a Tin Filter to Minimize Clumpy Artifacts on Foot and Ankle Dual-Energy CT","volume":"214","author":"Park","year":"2020","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0039","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13075-020-02283-z","article-title":"Dual-energy CT in gout patients: Do all colour-coded lesions actually represent monosodium urate crystals?","volume":"22","author":"Christiansen","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0040","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/annrheumdis-2017-212046","article-title":"Presence of monosodium urate crystal deposition by dual-energy CT in patients with gout treated with allopurinol","volume":"77","author":"Dalbeth","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0041","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/ard.61.1.52","article-title":"Imaging of tophaceous gout: computed tomography provides specific images compared with magnetic resonance imaging and ultrasonography","volume":"61","author":"Gerster","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0042","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jacc.2014.12.036","article-title":"Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC)","volume":"65","author":"Patel","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0043","doi-asserted-by":"crossref","DOI":"10.1097\/RLI.0000000000000756","article-title":"Dual-Energy Computed Tomography for Detection and Characterization of Monosodium Urate, Calcium Pyrophosphate, and Hydroxyapatite: A Phantom Study on Diagnostic Performance","author":"Dossing","year":"2021","journal-title":"Invest Radiol"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0044","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4329\/wjr.v12.i8.184","article-title":"Quantification of uric acid in vasculature of patients with gout using dual-energy computed tomography","volume":"12","author":"Barazani","year":"2020","journal-title":"World J Radiol"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0045","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/annrheumdis-2017-211343","article-title":"Advanced imaging assessment of gout: comparison of dual-energy CT and MRI with anatomical pathology","volume":"77","author":"Chhana","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0046","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1093\/eurheartj\/ehr054","article-title":"Intraplaque haemorrhages as the trigger of plaque vulnerability","volume":"32","author":"Michel","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0047","first-page":"871","article-title":"Pathologic changes in gout; survey of eleven necropsied cases","volume":"32","author":"Levin","year":"1956","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0048","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1194\/jlr.M018077","article-title":"Identification of cholesterol crystals in plaques of atherosclerotic mice using hyperspectral CARS imaging","volume":"52","author":"Lim","year":"2011","journal-title":"J Lipid Res"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0049","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9103204","article-title":"Systemic Urate Deposition: An Unrecognized Complication of Gout?","volume":"9","author":"Khanna","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0050","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.atherosclerosis.2017.03.025","article-title":"Clinical application of effective atomic number for classifying non-calcified coronary plaques by dual-energy computed tomography","volume":"261","author":"Nakajima","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0051","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/art.40848","article-title":"Clinical Utility of Multi-Energy Spectral Photon-Counting Computed Tomography in Crystal Arthritis","volume":"71","author":"Stamp","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0052","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keab125","article-title":"Multi-energy photon-counting computed tomography versus other clinical imaging techniques for the identification of articular calcium crystal deposition","author":"Bernabei","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0053","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.7150\/thno.53755","article-title":"Highly specific and label-free histological identification of microcrystals in fresh human gout tissues with stimulated Raman scattering","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0054","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/art.39638","article-title":"A Point-of-Care Raman Spectroscopy-Based Device for the Diagnosis of Gout and Pseudogout: Comparison With the Clinical Standard Microscopy","volume":"68","author":"Li","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.06.009_bib0055","doi-asserted-by":"crossref","DOI":"10.3390\/jfb10020018","article-title":"Adsorption of Proteins on m-CPPD and Urate Crystals Inhibits Crystal-induced Cell Responses: Study on Albumin-crystal Interaction","volume":"10","author":"Renaudin","year":"2019","journal-title":"J Funct Biomater"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221001232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221001232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:08:43Z","timestamp":1758733723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017221001232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0049017221001232"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.06.009","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and characterization of peripheral vascular color-coded DECT lesions in gout and non-gout patients: The VASCURATE study","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}